proteasome/ubiquitin modulators (ProScript)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameproteasome/ubiquitin modulators (ProScript)
Drug Alias Nameantimalarials (ProScript)cachexia therapy (Proscript/Roche)ubiquitination cascade (Proscript/Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsCachexiaInflammationAsthma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeukositeHoechst Marion Roussel LtdHarvard Medical School +[5] 
Active IndicationsN/A
Inactive IndicationsCachexiaInflammationAsthma +[7] 

Other Information

ATC CodeN/A
Related LinksN/A